The potential relevance of GCNT2 in Attention-deficit/hyperactivity disorder (ADHD) has been previously described, with GCNT2 CNVs only being found in ADHD patients and none in controls in earlier genome-wide analyses [41, 42]. Here, GCNT2 is linked to attention deficit-hyperactivity disorder.